Preclinical and clinical findings on first-in-class HIV maturation inhibitor discussed in Sydney Aug. 2, 2007
First small-molecule HIV-1 Tat-PP-1 inhibitors designed to inhibit HIV-1 transcription described Aug. 1, 2007
Significant antiviral activity with etravirine in HIV-positive, NNRTI-resistant patients July 31, 2007
Favorable profile emerges for second-generation HIV-1 maturation inhibitor from Panacos July 30, 2007
Fosalvudine tidoxil monotherapy is safe and effective in treatment-naive HIV-infected patients July 30, 2007
Maraviroc+optimized antiretroviral background therapy safe and effective:MOTIVATE 1 and 2 trials July 30, 2007
RSS